1. Murray, George C, Hines, Timothy J, Tadenev, Abigail L D, Züchner, Stephan, Burgess, Robert W. . Testing SIPA1L2 as a modifier of CMT1A using mouse models. In Journal of neuropathology and experimental neurology, 83, 318-330. doi:10.1093/jnen/nlae020. https://pubmed.ncbi.nlm.nih.gov/38472136/
2. Murray, George C, Hines, Timothy J, Tadenev, Abigail L D, Züchner, Stephan, Burgess, Robert W. 2023. Testing SIPA1L2 as a modifier of CMT1A using mouse models. In bioRxiv : the preprint server for biology, , . doi:10.1101/2023.11.30.569428. https://pubmed.ncbi.nlm.nih.gov/38076977/
3. Safaralizadeh, Tannaz, Jamshidi, Javad, Esmaili Shandiz, Ehsan, Tafakhori, Abbas, Darvish, Hossein. 2016. SIPA1L2, MIR4697, GCH1 and VPS13C loci and risk of Parkinson's diseases in Iranian population: A case-control study. In Journal of the neurological sciences, 369, 1-4. doi:10.1016/j.jns.2016.08.001. https://pubmed.ncbi.nlm.nih.gov/27653855/
4. Lee, Sanghun, Hecker, Julian, Hahn, Georg, Lange, Christoph, Prokopenko, Dmitry. 2024. On the effect heterogeneity of established disease susceptibility loci for Alzheimer's disease across different genetic ancestries. In Alzheimer's & dementia : the journal of the Alzheimer's Association, 20, 3397-3405. doi:10.1002/alz.13796. https://pubmed.ncbi.nlm.nih.gov/38563508/
5. Saadh, Mohamed J, Mahdi, Morug Salih, Allela, Omer Qutaiba B, Alsaikhan, Fahad, Farhood, Bagher. 2024. Critical role of miR-21/exosomal miR-21 in autophagy pathway. In Pathology, research and practice, 257, 155275. doi:10.1016/j.prp.2024.155275. https://pubmed.ncbi.nlm.nih.gov/38643552/
智鼠故事 
